Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study

TY - JOUR

T1 - Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study

AU - Gerratana, Lorenzo

AU - Ren, Yue

AU - Qamar, Rubina

AU - et al, null

AU - Complex General Surgical Oncology Faculty, Aurora

N1 - Ren Y, Reduzzi C, Regan MM, et al. Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study. Journal of Clinical Oncology. 2023;41(16_suppl):1059-1059. doi:10.1200/JCO.2023.41.16_suppl.1059

PY - 2023/6/1

Y1 - 2023/6/1

KW - circulating tumor cells

KW - CTC

KW - metastatic breast cancer

KW - hormones

UR - https://institutionalrepository.aah.org/auroragme/284

UR - https://libkey.io/libraries/1712/10.1200/JCO.2023.41.16_suppl.1059

U2 - 10.1200/JCO.2023.41.16_suppl.1059

DO - 10.1200/JCO.2023.41.16_suppl.1059

M3 - Meeting abstract

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -